Fused 1,2 thiazoles and 1,2 thiazines which act as nl3p3 modulators
WO2020234473A1
Anti-tdp-43 binding molecules and uses thereof
WO2020234405A1
Anti-abeta vaccine therapy
WO2020212593A1
Novel molecules for therapy and diagnosis
US2020253873A1
Method of safe administration of phosphorylated tau peptide vaccine
WO2020177952A1
Novel compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates
CA3102038A1
Novel compounds for diagnosis
KR20210005724A
Tetrahydrobenzofuro[2,3-C]pyridine and beta-carboline compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates
WO2019233745A1
Novel compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates
CN112165956A
Anti-abeta therapeutic vaccine
SG11202009917PA
Anti-abeta therapeutic vaccines
US2019211012A1
Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates
TW202017923A
Novel compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates
AU2019212170A1
Novel method of preparing an imaging compound
US2021041447A1
Azacarboline compounds for the detection of tau aggregates
WO2019145291A1
Gamma-carboline compounds for the detection of tau aggregates
CA3088232A1
Diagnostic compositions for pet imaging, a method for manufacturing the diagnostic composition and its use in diagnostics